BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7747989)

  • 1. [Histopathological diagnosis of papillary lesion of the breast].
    Akiyama F; Sakamoto G
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():32-5. PubMed ID: 7747989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal biopsy for diagnosis and treatment of intraductal lesions of the breast.
    Matsunaga T; Kawakami Y; Namba K; Fujii M
    Cancer; 2004 Nov; 101(10):2164-9. PubMed ID: 15484220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological study of en bloc breast sections in papillomatosis and its malignant transformation].
    Tian Y; Li S; Fu X
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):290-2. PubMed ID: 11038762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary lesions of the breast: To excise or observe?
    Khan S; Diaz A; Archer KJ; Lehman RR; Mullins T; Cardenosa G; Bear HD
    Breast J; 2018 May; 24(3):350-355. PubMed ID: 28845569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
    Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
    Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary lesions of the breast.
    Ibarra JA
    Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction.
    Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer Res; 1994 Apr; 54(7):1849-53. PubMed ID: 7907946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of papillary lesions at percutaneous breast biopsy.
    Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
    Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of invasive breast cancer and ductal carcinoma in situ in women with atypical papillary lesions of the breast.
    Cuneo KC; Dash RC; Wilke LG; Horton JK; Koontz BF
    Breast J; 2012 Sep; 18(5):475-8. PubMed ID: 22776070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
    Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
    Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
    Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
    Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign versus malignant papillary neoplasms of the breast. Diagnostic clues in fine needle aspiration cytology.
    Dawson AE; Mulford DK
    Acta Cytol; 1994; 38(1):23-8. PubMed ID: 8291351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductoscopy-based descriptors of intraductal lesions and their histopathologic correlates.
    Rose C; Bojahr B; Grunwald S; Frese H; Jäger B; Ohlinger R
    Onkologie; 2010; 33(6):307-12. PubMed ID: 20523094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary lesions of the breast: a review.
    Mulligan AM; O'Malley FP
    Adv Anat Pathol; 2007 Mar; 14(2):108-19. PubMed ID: 17471117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.